RADL3.SA logo
SAO · RADL3.SAMedical - PharmaceuticalsUpdated Nov 15, 2026

Raia Drogasil S.A. P/E ratio

Current valuation, historical context, and peer comparisons.

Current P/E ratio

16.83×

62.6% belowthe 10-year annual average

Share price14.29
÷
Earnings per share0.8493

Price and EPS in quote currency. Calculation details

Investors are paying 16.83 for every 1 of reported earnings per share.

P/E over time

2016 – 2025
Annual P/ESelected-period average 45.00×
3-year average34.56×3 positive annual observations
5-year average38.35×5 positive annual observations
10-year average45.00×10 positive annual observations
Peer median · TTM7.92×2 peers with positive P/E

Historical P/E ratios

Annual period-end data · 23 observations

RADL3.SA annual P/E history, newest first
Period endP/EChange
Dec 31, 202529.68×-0.9%
Dec 31, 202429.95×-32.0%
Dec 31, 202344.06×+19.1%
Dec 31, 202236.98×-27.6%
Dec 31, 202151.09×-37.6%
Dec 31, 202081.93×+81.3%
Dec 31, 201945.20×+27.9%
Dec 31, 201835.34×-34.5%
View all 23 annual observations +
RADL3.SA annual P/E history, newest first
Period endP/EChange
Dec 31, 201754.00×+29.2%
Dec 31, 201641.81×+34.0%
Dec 31, 201531.20×-7.6%
Dec 31, 201433.77×-21.5%
Dec 31, 201343.03×-34.2%
Dec 31, 201265.41×+24.0%
Dec 31, 201152.77×+129.6%
Dec 31, 201022.98×-15.2%
Dec 31, 200927.10×-31.3%
Dec 31, 200839.46×-60.7%
Dec 31, 2007100.46×+29.8%
Dec 31, 200677.39×-53.4%
Dec 31, 2005165.91×-18.2%
Dec 31, 2004202.78×-12.0%
Dec 31, 2003230.53×N/M

Change is relative to the preceding observation. N/M values are excluded from averages.

How RADL3.SA compares

Company P/E vs. peer trailing-12-month ratios

P/E comparison with RADL3.SA and provider-selected peers
CompanyP/E ratio
RADL3.SA logo
RADL3.SA This stockRaia Drogasil S.A.
16.83×
PGMN3.SA logo
PGMN3.SAEmpreendimentos Pague Menos S.A.
4.73×
PNVL3.SA logo
PNVL3.SADimed S.A. Distribuidora de Medicamentos
11.12×

Peers are selected by the data provider. Business models and earnings definitions can differ.

Put the numbers in context

What does RADL3.SA’s P/E tell you?

01

Start with its own history

At 16.83×, RADL3.SA is 62.6% below its 10-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

02

Compare like with like

The median of the 2 positive peer ratios above is 7.92×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.

03

Check what drives earnings

One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.

Keep your research connected

Take RADL3.SA into your spreadsheet

Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.

Explore Wisesheets
Quarterly P/E · latest quarter
=WISE("RADL3.SA", "PE Ratio", "LQ")
LQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data

Sources & calculation methodology

Current P/E

Share price 14.29 ÷ EPS 0.8493 = 16.83×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 15, 2026; this is not a real-time trading quote.

History & averages

Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.

Data definitions and limitations

The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.

RADL3.SA P/E ratio: common questions

The essentials behind the numbers.

Raia Drogasil S.A.'s current P/E is 16.83× based on the quote data last updated Nov 15, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.